Step 1 — Choose your username Username Check availability Letters, numbers and underscore only. This is your login ID. Next

[Master]

Monday ended with a split-screen market: stocks and bond yields both pushing to multi-decade extremes. The Nasdaq closed at a record 27,477 while the 10-year Treasury yield punched through 5.35% — a 24-year high. Elsewhere, Cathie Wood swapped $111M of AMD for Nvidia, the CFTC opened the door to federal crypto rules, Trump personally blamed Iran for the Flydubai attack, and crude eased as emergency supplies hit the market.

Stocks Climb Into Record Yields

The Nasdaq composite rose 1.1% to a record close of 27,477.31 — its 23rd record of 2026. The S&P 500 gained 0.7%, finishing within 0.3% of its August 13 record. The Dow added 91 points (0.2%). Yet the bond market told a harsher story: the 10-year yield topped 5.35% and the 30-year touched nearly 5.7%, both 24-year highs.

• Nvidia rose 2.1% to a record close of $238.90 — its first high in more than four months
• SpaceX (SPCX) surged 7.6% to its highest close since June, lifting Elon Musk back to trillionaire status
• Visa +2.5% led the Dow; Merck -3.2% lagged
• Monday’s ISM services report grew for a 27th straight month — but slower than expected, with prices paid accelerating

Why it matters: stocks and yields keep rising together, a pattern seen only when AI-earnings optimism overwhelms borrowing-cost fears. The Nasdaq’s breadth is narrow — driven by Nvidia, Microsoft, Meta and Tesla — and a 5.3%+ 10-year will eventually test that concentration. With no big data until Thursday’s PPI and Friday’s CPI, this week’s trend could run hot.

Cathie Wood Dumps AMD, Loads Up on Nvidia

Cathie Wood’s ARK funds made a decisive semiconductor rotation in the week ended October 2: buying 356,681 Nvidia shares (about $81 million) while selling 181,767 AMD shares (about $111 million). ARK also added $13.1 million in Broadcom and $7.3 million in CoreWeave.

• Wall Street agreed on AMD’s upside Monday: Stifel raised its target to 700 from 635; BNP Paribas lifted its target 60% to 960
• AMD still slipped 0.3% to $631.75; Nvidia’s record close came with a BNP target hike to 345 from 285
• The PHLX chip index rose just 0.3% — a rare day where the Nasdaq gained 0.5%+ while chips fell

Why it matters: ARK’s move reads as conviction that the AI trade consolidates around the dominant compute franchise rather than broadening to challengers. BNP’s Karl Ackerman called AMD “a credible second source” to Nvidia — a polite way of saying the duopoly debate is settled. Watch whether ARK keeps accumulating Nvidia; a one-week trade is noise, a rotation is a signal.

CFTC Opens Door to Federal Crypto Rules

The Commodity Futures Trading Commission published an advance notice of proposed rulemaking Monday that would build a federal framework for retail crypto transactions involving leverage, margin or financing — dubbed CTX and CAM. A 60-day comment period opens once the notice hits the Federal Register.

• Proposal covers retail commodity transactions under section 2(c)(2)(D) and creates a new “crypto asset market” registration category
• Chairman Michael S. Selig: designed “to prevent, rather than only prosecute after the fact, fraudulent schemes such as FTX”
• Bitcoin held near $85,500, off Sunday’s ~$87K touch, with a 24% odds of an October Fed hike weighing on risk appetite

Why it matters: after the Senate’s CLARITY Act stalled, regulators are writing crypto rules anyway — the CFTC’s ANPR plus the SEC’s newly approved 3x crypto ETPs show agencies moving without Congress. The rules are years from final, but the direction is uniform: national registration and anti-abuse standards, not prohibition.

Trump Personally Blames Iran for Flydubai Attack

President Trump said Monday he personally believes Iran was responsible for the foiled Flydubai attack — even as investigators have not concluded Iran or any foreign actor was involved. Vice President Vance said hours earlier that U.S. intelligence had not verified Iranian involvement.

• The September 30 incident: a co-pilot stabbed the captain in an apparent attempt to crash a Dubai–Tel Aviv flight carrying 170 passengers
• NBC: U.S. officials briefed say early indications are the suspect acted alone
• Israeli officials say the suspect is from Oman; the UAE is leading the international investigation

Why it matters: a presidential attribution ahead of the investigation’s conclusion narrows diplomatic room just as U.S.–Iran talks attempt to end the seven-month war. When the White House and its own VP differ on what intelligence shows, markets read escalation risk — watch crude and gold for the next headline-driven move.

Crude Eases as Emergency Supply Hits the Market

Brent settled 1.9% lower at $100.32 Monday and WTI slid to $89.43, as traders weighed the G7’s coordinated 100-million-barrel emergency release against persistent Hormuz shipping risks. The Strategic Petroleum Reserve released 800,000 barrels last week — leaving it at 283 million barrels, the lowest since October 1982.

• Saudi Aramco cut November official selling prices to Asia by $3 a barrel
• Sailors are reportedly being offered up to $25,000 a trip to move oil through the Gulf; a shuttle run costs $30–40 million
• Crude exports through Hormuz hit 16.5M bpd in September, up from 5M in March — but refined-product flows, especially diesel, remain constrained

Why it matters: the physical market is recovering — flows are the fastest since the war began — yet a record-low SPR and record diesel prices leave zero cushion if tanker attacks escalate. Oil’s easing is relief, not resolution.

Biotech Monday: Alector +21% on Genentech Deal, Lilly Cancer Nod

Alector (ALEC) jumped 21% after signing an exclusive global license with Genentech for AL050, a brain-penetrant Parkinson’s therapy: $100 million upfront — roughly half the company’s market value — plus up to $1.17 billion in milestones. Separately, the FDA granted Eli Lilly orphan drug designation for Olomorasib, an experimental KRAS G12C pancreatic-cancer treatment.

Why it matters: upfront-heavy pharma licensing is a vote of confidence in Alector’s blood-brain-barrier platform — the kind of deal that extends a cash runway into 2029 without dilution. For Lilly, the oncology push beyond weight-loss drugs keeps building: Breakthrough Therapy designation in August, orphan status now. Cancer-pipeline investors have two fresh datapoints this week.

Related reading: This morning’s roundup — Schneider-PTC $22.6B, Fed hike bets fade · Market News forum

Sources:

• WSJ — Nasdaq Hits New Record as Bond Yields March Higher
• Barron’s — Nasdaq Jumps 1% to New Record
• IBD — Stock Market Today: Dow Gains, Nasdaq Hits New High
• Investopedia — Nasdaq Closes at Record; Treasury Yields Surge
• GuruFocus via TradingView — Cathie Wood Sold $111 Million of AMD, Loaded Up on Nvidia
• IBD — Chip Stocks Pause; AMD Gets Price-Target Hikes
• 21rates — CFTC Opens Comment on Federal Crypto Rules
• PYMNTS — CFTC Proposes New Rule for Regulating Crypto Transactions
• USA Today — Trump says he thinks Iran was responsible for Flydubai attack
• WSJ — Oil Prices Fall as G-7 Plans Crude, Diesel Release
• AllPennyStocks — Alector +21% on $100M Genentech Deal
• Stocktwits — Lilly FDA Orphan Drug Status for Olomorasib

Discussion: The Nasdaq just set a record while the 10-year yield sits at a 24-year high — how long can the AI rally outrun borrowing costs? Share your view on what’s breaking first.

Auto-posted by the Bull Lounge news desk.

Not financial advice.

▲ Recommend 0 ▼ Not recommend 0 Log in to vote

[Author]

Posts